The administration of probiotics and synbiotics in immune compromised adults: Is it safe?

Beneficial Microbes

Volumn 6, Issue 1, 2015, Pages 3-17

  Van den Nieuwboer, M ^a   Brummer, R J ^b   Guarner, F ^c   Morelli, L ^d   Cabana, M ^e   Claassen, E ^a,f  

^a ATHENA INSTITUTE   (Netherlands)

^b ÖREBRO UNIVERSITY   (Sweden)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Food safety legislation; Immunocompromised people; Prebiotics; Probiotics; Synbiotics

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL STRAIN; BIFIDOBACTERIUM LONGUM; COLONY FORMING UNIT; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE DISEASE; GASTROINTESTINAL DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION; INFLAMMATORY BOWEL DISEASE; KIDNEY DISEASE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LEUCONOSTOC MESENTEROIDES; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MEDIASTINUM DISEASE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PEDIOCOCCUS PENTOSACEUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; RHEUMATOID ARTHRITIS; SACCHAROMYCES BOULARDII; SKIN DISEASE; STREPTOCOCCUS THERMOPHILUS; THORAX DISEASE; TREATMENT DURATION; URINARY TRACT DISEASE; ADULT; ADVERSE DRUG REACTION; CLINICAL TRIAL (TOPIC);

ADULT; CLINICAL TRIALS AS TOPIC; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; PROBIOTICS; SYNBIOTICS;

EID: 84920969881     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2014.0079     Document Type: Article

References (101)

1. Agrawal, A., Sharma, B.C., Sharma, P. and Sarin, S.K., 2012. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. American Journal of Gastroenterology 107: 1043-1050.
2. Alfaleh, K. and Bassler, D., 2008. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Systemic Review CD005496.
3. Alonso, V.R. and Guarner, F., 2013. Linking the gut microbiota to human health. British Journal of Nutrition 109: S21-S26.
4. Alverdy, J.C., Laughlin, R.S. and Wu, L., 2003. Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Critical Care Medicine 31: 598-607.
5. Antoni, L., Nuding, S., Wehkamp, J. and Stange, E.F., 2014. Intestinal barrier in inflammatory bowel disease. World Journal of Gastroenteroly 20: 1165-1179.
6. Anukam, K.C., Osazuwa, E.O., Osadolor, H.B., Bruce, A.W. and Reid, G., 2008. Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. Journal Of Clinical Gastroenterology 42: 239-243.
7. Baigrie, R.J., Lamont, P.M., Kwiatkowski, D., Dallman, M.J. and Morris, P.J., 1992. Systemic cytokine response after major surgery. British Journal of Surgery 79: 757-760.
8. Barraud, D., Blard, C., Hein, F., Marçon, O., Cravoisy, A., Nace, L., Alla, F., Bollaert, P.E. and Gibot, S., 2010. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Medicine 36: 1540-1547.
9. Barraud, D., Bollaert, P.E. and Gibot, S., 2013. Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest 143: 646-655.
10. Besselink, M.G.H., Timmerman, H.M., Van Minnen, L.P., Akkermans, L.M.A. and Gooszen, H.G., 2005. Prevention of infectious complications in surgical patients: potential role of probiotics. Digestive Surgery 22: 234-244.
11. Besselink, M.G., Van Santvoort, H.C., Buskens, E., Boermeester, M.A., Van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L., Van Ramshorst, B., Witteman, B.J.M., Rosman, C., Ploeg, R.J., Brink, M.A., Schaapherder, A.F.M., Dejong, C.H.C., Wahab, P.J., Van Laarhoven, C.J.H.M., Van der Harst, E., Van Eijck, C.H.J., Cuesta, M.A., Akkermans, L.M.A. and Gooszen, H.G., 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 371: 651-659.
12. Bouilly-Gauthier, D., Jeannes, C., Maubert, Y., Duteil, L., Queille-Roussel, C., Piccardi, N., Montastier, C., Manissier, P., Piérard, G. and Ortonne, J.P., 2010. Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. British Journal of Dermatology 163: 536-543.
13. Brenchley, J.M., Price, D.A., Schacker, T.W., Asher, T.E., Silvestri, G., Rao, S., Kazzaz, Z., Borstein, E., Lambotte, O., Altmann, D., Blazar, B.R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J.N., Hecht, F.M., Picker, L.J., Lederman, M.M., Deeks, S.G. and Douek, D.C., 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 12: 1365-1371.
14. Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E. and Lorvidhaya, V., 2010. Research randomized controlled trial of live Lactobacillus acidophilus plus Bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiation Oncology 5: 31.
15. Cimperman, L., Bayless, G., Best, K., Diligente, A., Mordarski, B., Oster, M., Smith, M., Vatakis, F., Wiese, D., Steiber, W. and Katz, J., 2011. A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. Journal of Clinical Gastroenterology 45: 785-789.
16. Claassen, E., Essbai, J., Rutgers, T. and Van Deventer, S., 2010. How safe are probiotics? Part 2: literature. Available at: http://www.infectieziektenplatform.nl/specialisme/hepatitis/33111.
17. Clayburgh, D.R., Shen, L. and Turner, J.R., 2004. A porous defense: the leaky epithelial barrier in intestinal disease. Laboratory Investigation 84: 282-291.
18. Dandekar, S., 2007. Pathogenesis of HIV in the gastrointestinal tract. Current HIV/AIDS Reports 4: 10-15.
19. De los Angeles Pineda, M., Thompson, S.F., Summers, K., De Leon, F., Pope, J. and Reid, G., 2011. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical Science Monitor 17: CR347.
20. Diepenhorst, G.M., Van Ruler, O., Besselink, M G., Van Santvoort, H.C., Wijnandts, P.R., Renooij, W., Gouma, D.J., Gooszen, H.G. and Boermeester, M.A., 2011. Influence of prophylactic probiotics and selective decontamination on bacterial translocation in patients undergoing pancreatic surgery: a randomized controlled trial. Shock 35: 9-16.
21. Ebert, E.C. and Hagspiel, K.D., 2011. Gastrointestinal and hepatic manifestations of rheumatoid arthritis. Digestive Diseases and Sciences 56: 295-302.
22. Eguchi, S., Takatsuki, M., Hidaka, M., Soyama, A., Ichikawa, T. and Kanematsu, T., 2011. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. American Journal of Surgery 201: 498-502.
23. Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V. and Rodés, J., 2002. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35: 140-148.
24. Ferrie, S. and Daley, M., 2011. Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness randomized controlled trial. Journal of Parenteral and Enteral Nutrition 35: 43-49.
25. Fiuza, C., Salcedo, M., Clemente, G., and Tellado, J. M., 2000. in vivo neutrophil dysfunction in cirrhotic patients with adVanced liver disease. Journal of Infectious Diseases, 182(2), 526-533.
26. Fleming, J.O., Isaak, A., Lee, J.E., Luzzio, C.C., Carrithers, M.D., Cook, T.D., Field, A.S., Boland, J. and Fabry, Z., 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Multiple Sclerosis Journal 17: 743-754.
27. Food and Agriculture Organization of the United Nations (FAO), 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Available at: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf.
28. Frohmader, T.J., Chaboyer, W.P., Robertson, I.K. and Gowardman, J., 2010. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL# 3: a pilot trial. American Journal of Critical Care 19: e1-e11.
29. Fujimori, S., Gudis, K., Mitsui, K., Seo, T., Yonezawa, M., Tanaka, S., Tatsuguchi, A. and Sakamoto, C., 2009. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25: 520-525.
30. Gao, X.W., Mubasher, M., Fang, C.Y., Reifer, C. and Miller, L.E., 2010. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology 105: 1636-1641.
31. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A. and Braga, M., 2010. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World Journal of Gastroenterology 16: 167.
32. González-Hernández, L.A., Jave-Suarez, L.F., Fafutis-Morris, M., Montes-Salcedo, K.E., Valle-Gutierrez, L.G., Campos-Loza, A.E., Enciso-Gómez, L.F. and Andrade-Villanueva, J.F., 2012. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial. Nutrition Journal 11: 90.
33. Guarner, F., Khan, A.G., Garisch, J., Eliakim, R., Gangl, A., Thomson, A., Krabshuis, J., Lemair, T., Kaufmann, P., De Paula, J.A., Fedorak, R., Shanahan, F., Sanders, M.E., Szajewska, H., Ramakrishna, B.S., Karakan, T. and Kim, N., 2012. World gastroenterology organisation global guidelines: probiotics and prebiotics October 2011. Journal of Clinical Gastroenterology 46: 468-481.
34. Hempel, S., Newberry, S.J., Maher, A.R., Wang, Z., Miles, J.N., Shanman, R., Johnsen, R. and Shekelle, P.G., 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307: 1959-1969.
35. Hempel, S., Newberry, S., Ruelaz, A., Wang, Z., Miles, J.N.V., Suttorp, M.J., Johnsen, B., Shanman, R., Slusser, W., Fu, N., Smith, A., Roth, E., Polak, J., Motala, A., Perry, T. and Shekelle, P.G., 2011. Safety of probiotics to reduce risk and prevent or treat disease. Evidence Report/Technology Assessment No. 200. AHRQ Publication No. 11-E007. Agency for Healthcare Research and Quality, Rockville, MD, USA. Available at: http://www.ahrq.gov/clinic/tp/probiotictp.htm.
36. Hemsworth, J.C., Hekmat, S. and Reid, G., 2012. Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 3: 414-419.
37. Horvat, M., Krebs, B., Potrc, S., Ivanecz, A. and Kompan, L., 2010. Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wiener Klinische Wochenschrift, 122: 26-30.
38. Hummelen, R., Changalucha, J., Butamanya, N.L., Cook, A., Habbema, J.D.F. and Reid, G., 2010. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. International Journal of Gynecology and Obstetrics, 111: 245-248.
39. Hummelen, R., Changalucha, J., Butamanya, N.L., Koyama, T.E., Cook, A., Habbema, J.D. F. and Reid, G., 2011a. Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2: 80-85.
40. Hummelen, R., Hemsworth, J., Changalucha, J., Butamanya, N.L., Hekmat, S., Habbema, J.D.F. and Reid, G., 2011b. Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients 3: 897-909.
41. Irvine, S.L., Hummelen, R. and Hekmat, S., 2011. Probiotic yogurt consumption may improve gastrointestinal symptoms, productivity, and nutritional intake of people living with human immunodeficiency virus in Mwanza, Tanzania. Nutrition Research 31: 875-881.
42. Irvine, S.L., Hummelen, R., Hekmat, S., Looman, C.W., Habbema, J.D.F. and Reid, G., 2010. Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. Journal of Clinical Gastroenterology 44: e201-e205.
43. Ishikawa, H., Matsumoto, S., Ohashi, Y., Imaoka, A., Setoyama, H., Umesaki, Y., Tanaka, R. and Otani, T., 2011. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84: 128-133.
44. Jenks, K., Stebbings, S., Burton, J., Schultz, M., Herbison, P. and Highton, J., 2010. Probiotic therapy for the treatment of spondyloarthritis: a randomized controlled trial. Journal of Rheumatology 37: 2118-2125.
45. Kamada, N., Chen, G.Y., Inohara, N. and Núñez, G., 2013. Control of pathogens and pathobionts by the gut microbiota. Nature Immunology 14: 685-690.
46. Kirpich, I.A., Solovieva, N.V., Leikhter, S.N., Shidakova, N.A., Lebedeva, O.V., Sidorov, P.I., Bazhukova, T.A., Soloviev, A.G., Barve, S.S., McClain, C.J. and Cave, M., 2008. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42: 675-682.
47. Klarin, B., Molin, G., Jeppsson, B. and Larsson, A., 2008. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Critical Care 12: R136.
48. Knight, D.J., Gardiner, D., Banks, A., Snape, S.E., Weston, V.C., Bengmark, S. and Girling, K.J., 2009. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Medicine 35: 854-861.
49. Kollef, M.H., 2005. What is ventilator-associated pneumonia and why is it important? Respiratory Care 50: 714-724.
50. Lee, H.J., Waller, R.D., Stebbings, S., Highton, J., Orlovich, D.A., Schmierer, D. and Fawcett, J.P., 2010. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. International Journal of Rheumatic Diseases 13: 48-54.
51. Leserman, J., Petitto, J.M., Gu, H., Gaynes, B.N., Barroso, J., Golden, R.N., Perkins, D.O., Folds, J.D. and Evans, D.L., 2002. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychological Medicine 32: 1059-1073.
52. Liu, J.E., Zhang, Y., Zhang, J., Dong, P.L., Chen, M. and Duan, Z.P., 2010. Probiotic yogurt effects on intestinal flora of patients with chronic liver disease. Nursing Research 59: 426-432.
53. Liu, Z.H., Huang, M.J., Zhang, X.W., Wang, L., Huang, N.Q., Peng, H., Lan, P., Peng, J.S., Yang, Z., Xia, Y., Liu, W.J., Yang, J., Qin, H.L. and Wang, J.P., 2013. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. American Journal of Clinical Nutrition 97: 117-126.
54. Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., Jiang, Y., Zhang, H., Yang, Z., Wang, Y. and Zheng, Q., 2011. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study. Alimentary Pharmacology and Therapeutics 33: 50-63.
55. Malaguarnera, M., Gargante, M.P., Malaguarnera, G., Salmeri, M., Mastrojeni, S., Rampello, L., Pennisi, G., Volti, G.L. and Galvano, F., 2010. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. European Journal of Gastroenterology and Hepatology 22: 199-206.
56. Mandel, D., Eichas, K. and Holmes, J., 2010. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine 10: 1.
57. Mangell, P., Thorlacius, H., Syk, I., Ahrné, S., Molin, G., Olsson, C. and Jeppsson, B., 2012. Lactobacillus plantarum 299v does not reduce enteric bacteria or bacterial translocation in patients undergoing colon resection. Digestive Diseases and Sciences 57: 1915-1924.
58. Marchetti, G., Tincati, C. and Silvestri, G., 2013. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clinical Microbiology Reviews 26: 2-18.
59. Matthes, H., Krummenerl, T., Giensch, M., Wolff, C. and Schulze, J., 2010. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917. BMC Complementary and Alternative Medicine 10: 13.
60. Mehandru, S., Poles, M.A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P. and Markowitz, M., 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. Journal of Experimental Medicine 200: 761-770.
61. Mennigen, R. and Bruewer, M., 2009. Effect of probiotics on intestinal barrier function. Annals of the New York Academy of Sciences 1165: 183-189.
62. Mittal, V.V., Sharma, B.C., Sharma, P. and Sarin, S.K., 2011. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European Journal of Gastroenterology and Hepatology 23: 725-732.
63. Mookerjee, R.P., Stadlbauer, V., Lidder, S., Wright, G.A., Hodges, S.J., Davies, N.A. and Jalan, R., 2007. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46: 831-840.
64. Morrow, L.E., Gogineni, V. and Malesker, M.A., 2012. Probiotic, prebiotic, and synbiotic use in critically ill patients. Current Opinion in Critical Care 18: 186-191.
65. Morrow, L.E., Kollef, M.H. and Casale, T.B., 2010. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. American journal of Respiratory and Critical Care Medicine 182: 1058.
66. Peguet-Navarro, J., Dezutter-Dambuyant, C., Buetler, T., Leclaire, J., Smola, H., Blum, S., Bastien, P., Breton, L. and Gueniche, A., 2008. Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. European Journal of Dermatology 18: 504-511.
67. Peral, M.C., Huaman Martinez, M.A. and Valdez, J.C., 2009. Bacteriotherapy with Lactobacillus plantarum in burns. International Wound Journal 6: 73-81.
68. Pereg, D., Kotliroff, A., Gadoth, N., Hadary, R., Lishner, M. and Kitay-Cohen, Y., 2011. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition 27: 177-181.
69. Pineiro, M., Asp, N.G., Reid, G., Macfarlane, S., Morelli, L., Brunser, O. and Tuohy, K., 2008. FAO technical meeting on prebiotics. Journal of Clinical Gastroenterology 42: S156-S159.
70. Pithadia, A.B. and Jain, S., 2011. Treatment of inflammatory bowel disease (IBD). Pharmacological Reports 63: 629-642.
71. Pozzoni, P., Riva, A., Bellatorre, A.G., Amigoni, M., Redaelli, E., Ronchetti, A., Stefani, M., Tironi, R., Molteni, E.E., Conte, D., Casazza, G. and Colli, A., 2012. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. American Journal of Gastroenterology 107: 922-931.
72. Ranganathan, N., Friedman, E.A., Tam, P., Rao, V., Ranganathan, P. and Dheer, R., 2009. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Current Medical Research and Opinion 25: 1919-1930.
73. Riordan, S.M. and Williams, R., 2006. The intestinal flora and bacterial infection in cirrhosis. Journal of Hepatology 45: 744-757.
74. Saavedra, J.M., 2001. Clinical applications of probiotic agents. American Journal of Clinical Nutrition 73: 1147S-1151S.
75. Salminen, M.K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V. and Järvinen, A., 2004. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 38: 62-69.
76. Salminen, M.K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., Sarna, S., Valtonen, V. and Järvinen, A., 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 35: 1155-1160.
77. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A., 2013. An update on the use and investigation of probiotics in health and disease. Gut 62: 787-796.
78. Schroeder, R.A., Marroquin, C.E., Bute, B.P., Khuri, S., Henderson, W.G. and Kuo, P.C., 2006. Predictive indices of morbidity and mortality after liver resection. Annals of Surgery 243: 373.
79. Schuijt, T.J., Van der Poll, T., De Vos, W.M. and Wiersinga, W.J., 2013. The intestinal microbiota and host immune interactions in the critically ill. Trends in Microbiology 21: 221-229.
80. Schunter, M., Chu, H., Hayes, T.L., McConnell, D., Crawford, S.S., Luciw, P.A., Bengmark, S., Asmuth, D.M., Brown, J., Bevins, C.L., Shacklett, B.L. and Critchfield, J.W., 2012. Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection. BMC Complementary and Alternative Medicine 12: 84.
81. Sharma, B., Srivastava, S., Singh, N., Sachdev, V., Kapur, S. and Saraya, A., 2011. Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial. Journal of Clinical Gastroenterology 45: 442-448.
82. Shimizu, K., Ogura, H., Goto, M., Asahara, T., Nomoto, K., Morotomi, M., Matsushima, A., Tasaki, O., Fujita, K., Hosotsubo, H., Kuwagata, H., Tanaka, H., Shimazu, T. and Sugimoto, H., 2009. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Digestive Diseases and Sciences 54: 1071-1078.
83. Song, H.J., Kim, J.Y., Jung, S., Kim, S.E., Park, H.S., Jeong, Y., Hong, S.P., Cheon, J.H., Kim, W.H., Kim, H.J., Ye, B.D., Yang, S.K., Kim, S.W., Shin, S.J., Kim. H.S., Sung, J.K. and Kim, E.Y., 2010. Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. Journal of Korean Medical Science 25: 1784-1791.
84. Souza, D.N.P.D. and Jorge, M.T., 2012. The effect of Lactobacillus casei and Bifidobacterium breve on antibiotic-associated diarrhea treatment: randomized double-blind clinical trial. Revista da Sociedade Brasileira de Medicina Tropical 45: 112-116.
85. Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G.A., Davies, N.A. and Jalan, R., 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology 48: 945-951.
86. Steed, H., Macfarlane, G.T., Blackett, K.L., Bahrami, B., Reynolds, N., Walsh, S.V., Cummings, J.H. and Macfarlane, S., 2010. Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease. Alimentary Pharmacology and Therapeutics 32: 872-883.
87. Stephens, J.H. and Hewett, P.J., 2012. Clinical trial assessing VSL# 3 for the treatment of anterior resection syndrome. ANZ Journal of Surgery 82: 420-427.
88. Tan, M., Zhu, J.C., Du, J., Zhang, L.M. and Yin, H.H., 2011. Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study. Critical Care 15: R290.
89. Tanaka, K., Yano, M., Motoori, M., Kishi, K., Miyashiro, I., Ohue, M., Ohigashi, H., Asahara, T., Nomoto, K. and Ishikawa, O., 2012. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 152: 832-842.
90. Tandon, P., Moncrief, K., Madsen, K., Arrieta, M.C., Owen, R.J., Bain, V.G., Wong, W.W. and Ma, M.M., 2009. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Liver International 29: 1110-1115.
91. Tran, K.T., Smeenk, H.G., Van Eijck, C.H., Kazemier, G., Hop, W.C., Greve, J.W.G., Terpstra, O.T., Zijlstra, J.A., Klinkert, P. and Jeekel, H., 2004. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Annals of Surgery 240: 738.
92. Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G.M., Forti, G., Morini, S., Hassan, C., Pistoia, M.A., Modeo, M.E., Rodino, S., D'Amico, T., Sebkova, L., Sacca, N., Di Giulio, E., Luzza, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S. and Gasbarrini, A., 2010. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL# 3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. American Journal of Gastroenterology 105: 2218-2227.
93. Usami, M., Miyoshi, M., Kanbara, Y., Aoyama, M., Sakaki, H., Shuno, K., Hirata, K., Takahashi, M., Ueno, K., Tabata, S., Asahara, T. and Nomoto, K., 2011. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. Journal of Parenteral and Enteral Nutrition 35: 317-328.
94. Van den Nieuwboer, M., Claassen, E., Morelli, L., Guarner, F. and Brummer, R.J., 2014. Probiotic and synbiotic safety in infants under two years of age. Beneficial Microbes 5: 45-60.
95. Vincent, J.L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., Moreno, R., Lipman, J., Gomersall, C., Sakr, Y. and Reinhart, K., 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302: 2323-2329.
96. Von Wright, A., 2005. Regulating the safety of probiotics - the European approach. Current Pharmaceutical Design 11: 17-23.
97. Vyas, U. and Ranganathan, N., 2012. Probiotics, prebiotics, and synbiotics: gut and beyond. Gastroenterology Research and Practice 2012: 16.
98. Wagner, R.D. and Balish, E., 1998. Potential hazards of probiotic bacteria for immunodeficient patients. Bulletin de l'Institut Pasteur 96: 165-170.
99. Wang, Q., Dong, J. and Zhu, Y., 2012. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. Journal of Pediatric Surgery 47: 241-248.
100. Watkinson, P.J., Barber, V.S., Dark, P. and Young, J.D., 2007. The use of pre-pro-and synbiotics in adult intensive care unit patients: systematic review. Clinical Nutrition 26: 182-192.
101. Zhang, J.W., Du, P., Gao, J., Yang, B.R., Fang, W.J. and Ying, C.M., 2012. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. American Journal of the Medical Sciences 343: 199-205.